High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.
Nature Medicine
Razavi, Pedram P; Li, Bob T BT; Brown, David N DN; Jung, Byoungsok B; Hubbell, Earl E; Shen, Ronglai R; Abida, Wassim W; Juluru, Krishna K; De Bruijn, Ino I; Hou, Chenlu C; Venn, Oliver O; Lim, Raymond R; Anand, Aseem A; Maddala, Tara T; Gnerre, Sante S; Vijaya Satya, Ravi R; Liu, Qinwen Q; Shen, Ling L; Eattock, Nicholas N; Yue, Jeanne J; Blocker, Alexander W AW; Lee, Mark M; Sehnert, Amy A; Xu, Hui H; Hall, Megan P MP; Santiago-Zayas, Angie A; Novotny, William F WF; Isbell, James M JM; Rusch, Valerie W VW; Plitas, George G; Heerdt, Alexandra S AS; Ladanyi, Marc M; Hyman, David M DM; Jones, David R DR; Morrow, Monica M; Riely, Gregory J GJ; Scher, Howard I HI; Rudin, Charles M CM; Robson, Mark E ME; Diaz, Luis A LA; Solit, David B DB; Aravanis, Alexander M AM; Reis-Filho, Jorge S JS
Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease.
British Journal Of Haematology
Kortüm, Klaus M KM; Langer, Christian C; Monge, Jorge J; Bruins, Laura L; Egan, Jan B JB; Zhu, Yuan X YX; Shi, Chang Xin CX; Jedlowski, Patrick P; Schmidt, Jessica J; Ojha, Juhi J; Bullinger, Lars L; Liebisch, Peter P; Kull, Miriam M; Champion, Mia D MD; Van Wier, Scott S; Ahmann, Gregory G; Rasche, Leo L; Knop, Stefan S; Fonseca, Rafael R; Einsele, Hermann H; Stewart, A Keith AK; Braggio, Esteban E